SCHEMBL6831063

SCHEMBL6831063

Nc1ccc(OC(=O)NCCn2cccn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.45
THRB P10828 3/20 0.44
NAMPT P43490 2/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
MAPT P10636 1/20 0.39
BLM P54132 1/20 0.39
CASP6 P55212 1/20 0.39
GFER P55789 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TAAR1 Q96RJ0 2/20 0.39
NPC1 O15118 1/20 0.39
MGLL Q99685 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829032 0.83 KMT2A (0.40) RAB9ATHRBNAMPTLMNAKMT2A
SCHEMBL6923840 0.83 MGLL (0.59) RAB9ATHRBKMT2ASMN1; SMN2GAA
SCHEMBL13724309 0.74 KMT2A (0.52) THRBKMT2ASMN1; SMN2GAAKDM4E
SCHEMBL25238984 0.73 MGLL (0.60) THRBSMN1; SMN2GAAKDM4EGLA
SCHEMBL6647923 0.72 NLRP3 (0.48) THRBNAMPTLMNAKMT2A
SCHEMBL3861581 0.72 LTA4H (0.45) RAB9ATHRBLMNAKMT2ASMN1; SMN2
SCHEMBL18474099 0.72 MGLL (0.67) MGLL
SCHEMBL28230841 0.71 TDP1 (0.43) THRBNAMPTLMNAKMT2AGAA
SCHEMBL6679215 0.70 SMN1; SMN2 (0.54) RAB9ALMNAKMT2ASMN1; SMN2GAA
SCHEMBL6920000 0.70 MGLL (0.41) RAB9ATHRBNAMPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed